105 related articles for article (PubMed ID: 10536809)
1. [The use of sirdalud in cerebral palsy in children].
Brin IL; Kurenkov AL; Gotlib VIa
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(10):30-3. PubMed ID: 10536809
[TBL] [Abstract][Full Text] [Related]
2. [Sirdalud in the practice of the pediatric neurologist].
Shumilina AP; Guzeva VI; Skoromets AA
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(10):45-6. PubMed ID: 9424348
[No Abstract] [Full Text] [Related]
3. [The use of sirdalud in painful muscle tonic syndromes].
Damulin IV
Ter Arkh; 1997; 69(10):68-72. PubMed ID: 9471796
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
5. [The use of sirdalud in the treatment of spasticity in infantile cerebral palsy].
Maksimov OG; Secheĭko MV; Andriĭchuk EL
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(3):22-3. PubMed ID: 10205837
[No Abstract] [Full Text] [Related]
6. Oral baclofen increases maximal voluntary neuromuscular activation of ankle plantar flexors in children with spasticity due to cerebral palsy.
van Doornik J; Kukke S; McGill K; Rose J; Sherman-Levine S; Sanger TD
J Child Neurol; 2008 Jun; 23(6):635-9. PubMed ID: 18281622
[TBL] [Abstract][Full Text] [Related]
7. [The use of sirdalud MR in patients with multiple sclerosis].
Batysheva TT; Popova NF; Petrov SV; Kamchatnov PR; Zaĭtsev KA; Boĭko AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):57-60. PubMed ID: 21322181
[TBL] [Abstract][Full Text] [Related]
8. Biological fate of sirdalud in animals and man.
Koch P; Hirst DR; von Wartburg BR
Xenobiotica; 1989 Nov; 19(11):1255-65. PubMed ID: 2618078
[TBL] [Abstract][Full Text] [Related]
9. Continuous intrathecal baclofen therapy in children with cerebral palsy - when does improvement emerge?
Ramstad K; Jahnsen R; Lofterod B; Skjeldal OH
Acta Paediatr; 2010 Nov; 99(11):1661-5. PubMed ID: 19912148
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal baclofen infusion for ambulant children with cerebral palsy.
Brochard S; Remy-Neris O; Filipetti P; Bussel B
Pediatr Neurol; 2009 Apr; 40(4):265-70. PubMed ID: 19302938
[TBL] [Abstract][Full Text] [Related]
11. [The treatment of tension headache with sirdalud].
Filatova EG; Solov'eva AD; Danilov AB
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(11):36-8. PubMed ID: 9463035
[TBL] [Abstract][Full Text] [Related]
12. [Disorders of muscle tonus and their treatment with sirdalud in patients in the early recovery period of ischemic stroke].
Gekht AB; Burd GS; Selikhova MV; Iaish F; Beliakov VV
Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):22-9. PubMed ID: 9819884
[TBL] [Abstract][Full Text] [Related]
13. Modulation of soleus H-reflexes during gait in children with cerebral palsy.
Hodapp M; Klisch C; Mall V; Vry J; Berger W; Faist M
J Neurophysiol; 2007 Dec; 98(6):3263-8. PubMed ID: 17913993
[TBL] [Abstract][Full Text] [Related]
14. [Intrathecal baclofen for treatment of spasticity in patient with cerebral palsy--a preliminary report].
Jóźwiak M; Idzior M; Huber J; Szulc A; Grottel K
Chir Narzadow Ruchu Ortop Pol; 2003; 68(4):253-9. PubMed ID: 14702678
[TBL] [Abstract][Full Text] [Related]
15. The effect of continuous intrathecal baclofen on sitting in children with severe cerebral palsy.
Gray N; Vloeberghs M
Eur J Paediatr Neurol; 2014 Jan; 18(1):45-9. PubMed ID: 24100173
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy of sirdalud in the drug therapy of pain in the spine].
Iakhno NN; Damulin IV; Chernenko OA; Ianakaeva TA; Kondrat'eva ON; Kur'ianova PT
Ter Arkh; 1994; 66(10):10-2. PubMed ID: 7863433
[TBL] [Abstract][Full Text] [Related]
17. New approaches to managing spasticity in children with cerebral palsy.
Im D; McDonald CM
West J Med; 1997 Apr; 166(4):271. PubMed ID: 9168686
[No Abstract] [Full Text] [Related]
18. Analysis of gait and isokinetic movements for evaluation of antispastic drugs or physical therapies.
Knutsson E
Adv Neurol; 1983; 39():1013-34. PubMed ID: 6229155
[No Abstract] [Full Text] [Related]
19. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy.
Hoving MA; van Raak EP; Spincemaille GH; van Kranen-Mastenbroek VH; van Kleef M; Gorter JW; Vles JS;
Eur J Paediatr Neurol; 2009 May; 13(3):247-56. PubMed ID: 18590974
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up on continuous intrathecal Baclofen therapy in non-ambulant children with intractable spastic Cerebral Palsy.
Vles GF; Soudant DL; Hoving MA; Vermeulen RJ; Bonouvrié LA; van Oostenbrugge RJ; Vles JS
Eur J Paediatr Neurol; 2013 Nov; 17(6):639-44. PubMed ID: 23871360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
